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1. Introduction
   In Indian system of medicine, a large number of drugs 
from herbal or mineral origin have been advocated for 
various types of diseases and other different unwanted 
conditions in humans[1]. Ayurvedic medicines are largely 
based upon herbal and herbomineral preparations and 
have specific diagnostic and therapeutic principles[2]. 
Inflammation is a disorder involving localized increases in 
the number of leukocytes and a variety of complex mediator 
molecules[3]. Prostaglandins are ubiquitous substances that 
indicate and modulate cell and tissue responses involved in 
inflammation. Their biosynthesis has also been implicated 
in the pathophysiology of cardiovascular diseases, cancer, 
colonic adenomas and Alzheimer’s diseases[4,5]. Medicinal 
plants are believed to be an important source of new 
chemical substances with potential therapeutic effects[6,7]. 
The research into plants with alleged folkloric use as pain 
relievers, anti-inflammatory agents, should therefore be 
viewed as a fruitful and logical research strategy in the 
search for new analgesic and anti-inflammatory drugs.
  Indigofera cassioides (I. cassioides) Rottl. Ex. DC. (Syn: 
Indigofera pulchella Roxb.) belonging to the family 
Fabaceae, is a large shrub, distributed throughout the hills 
of India. The flowers and leaves of the plant are reported to 
be antiscorbutic, diuretic and alternative. A decoction of the 
root is given for cough and its powder is applied externally 
for chest pains. The leaves and roots are used for swelling 
of the stomach[8,9]. The leaves are used by various ethnic 
groups and native medical practitioners to treat much 
kind of diseases such as arthritis, inflammation, tumor 
and liver diseases. In our earlier studies, the plant extract 
exhibited a potent antioxidant and antitumor activity[10,11]. 
In continuation of our previous studies, the present study 
was aimed to evaluate the anti-inflammatory and analgesic 
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Journal of Acute Disease (2013)322-326
Contents lists available at ScienceDirect
Journal of Acute Disease
journal homepage: www.jadweb.org
323Raju Senthil Kumar et al./ Journal of Acute Disease (2013)322-326
activities of methanol extract of Indigofera cassioides (MEIC) 
on various experimental models.
2. Materials and methods
2.1. Chemicals
  Kappa carrageenan type III was obtained from Sigma, St. 
Louis, USA. Pentazocin was obtained from Ranbaxy, India. 
Aceclofenac and aspirin were obtained from Micro Labs, 
India. All other chemical used were of analytical grade.
2.2. Plant material and extraction
  Leaves of I. cassioides were collected from the Yercaud hills 
in the month of November 2008. The plant was authenticated 
by Dr. G.V.S. Murthy, Joint Director, Botanical Survey of 
India, Coimbatore, Tamilnadu, India. A voucher specimen 
is preserved in our laboratory for future reference (Voucher 
No. P. Ch. IC 003/2008). The plant material was shade 
dried, pulverized and extracted (500 g) with 80% methanol 
at room temperature for 72 h. The extract was filtered 
and concentrated to dryness under reduced pressure and 
controlled temperature (40 曟 to 50 曟) in a rotary evaporator. 
The extract was a dark brown solid weighing 41 g (yield, 8.2 
%) and was preserved in a vacuum desiccator at 4 曟 until 
further use.
2.3. Animals
  Male Wistar albino rats (150-200 g) and Swiss albino mice 
(20-25 g) were procured from Venkatershwara Enterprises, 
Bangalore, Karnataka, India, and used throughout the 
study. They were housed in microlon boxes in a controlled 
environment [temperature (25依2)℃ and 12 h dark/light 
cycle] with standard laboratory diet and water ad libitum. 
The study was conducted after obtaining Institutional Animal 
Ethical Committee (IAEC) clearance.
2.4. Anti-inflammatory activity
2.4.1. Carrageenan-induced rat paw edema
  The rats were divided into four groups (n=6). The different 
groups were treated orally with MEIC (200 & 400 mg/kg), 
Aceclofenac (10 mg/kg), and vehicle control (0.3% CMC, 1 
ml/kg/p.o.). The administration of extract and drugs was 
1 h prior to injection of 0.1 mL of 1% freshly prepared 
suspension of carrageenan in normal saline in the right hind 
paw sub plantar of each rat. The paw volume was measured 
initially and then at 1, 2 and 3 h after the carrageenan 
injection by using plethysmometer. The anti-inflammatory 
effect of MEIC was calculated by the following equation: -
Anti-inflammatory activity (%) = (1-Vt/Vc) × 100
Where Vt represents the paw volume in drug treated 
animals and Vc represents the paw volume of control groups 
animals[12].
2.4.2. Cotton pellet-induced granuloma
  The animals were divided into four groups of six animals in 
each group. The rats were anaesthetized and sterile cotton 
pellets weighing (10依1) mg was implanted subcutaneously 
into both sides of the groin region of each rat. Group I served 
as control and received the vehicle (0.3% CMC, 1 mL/kg/p.o.). 
Group II animals received aceclofenac at a dose of  10 mg/kg 
for the same period. MEIC at the concentration of 200 & 400 
mg/kg was administered orally to groups III and IV animals 
for seven consecutive days from the day of cotton pellet 
implantation. On 8th day the animals were anaesthetized 
and the pellets together with the granuloma tissues were 
carefully removed and made free from extraneous tissues. 
The wet pellets were weighed and then dried in an oven at 
60 曟 for 24 h to constant weight, after that the dried pellets 
were weighed again. Increment in the dry weight of the 
pellets was taken as a measure of granuloma formation. The 
antiproliferative effect of MEIC was compared with control 
[13].
2.5. Analgesic activity
2.5.1. Acetic acid induced writhing test
  The writhes were induced by intraperitoneal injection of 0.6 
%v/v acetic acid (80 mg/kg). Group I served as control (0.3% 
CMC, 1 mL/kg/p.o.) and group II animals received aspirin 
at a dose of 300 mg/kg. Two different doses of MEIC (200 & 
400 mg/kg) were administered orally to the group III and 
group IV. The extract and standard drug was administered 
30 min before chemical stimulus. The number of muscular 
contractions was counted over a period of 20 min and is 
expressed as writhing numbers[14]. 
2.5.2. Hot plate method
  The hot plate method in rats was performed by the method 
of Eddy and Leimbach[15]. The evaluated parameters were 
the latency time for paw licking and jumping responses 
on exposure to the hot plate surface, kept at (55依1) 曟. The 
animal was kept in the hot plate until it lifted one of its 
hind paws. For this method, the animals were divided into 
four groups of six animals each. Group I served as control 
(0.3% CMC, 1 mL/kg/p.o.). Group II received pentazocin at a 
dose of 5 mg/kg. Group III and IV received MEIC at a dose 
of 200 & 400 mg/kg orally. All the treatments were given 
30 min before the thermal stimulus and the response was 
determined at 60, 120 and 180 min. 
2.6. Statistical analysis
  All values were expressed as mean依SEM. Statistical 
analysis was performed with one way analysis of variance 
(ANOVA) followed by Tukey Kramer Multiple Comparison 
test. P values < 0.05 were considered to be statistically 
significant when compared to control.
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3. Results
3.1. Carrageenan induced rat paw edema
  The result of MEIC against carrageenan-induced paw 
edema is shown in Table 1. MEIC (200 & 400 mg/kg) gave 
significant (P<0.001) reduction of rat paw edema at all 
assessment times in dose dependent manner. The extract 
showed maximum inhibition of 66.32% at the dose of 400 mg/kg
after 3 h of drug treatment in carrageenan-induced paw 
edema whereas the standard drug showed 60% of inhibition.
3.2. Effect of MEIC on cotton pellet granuloma
  The effects of MEIC and aceclofenac on the proliferative 
phase of inflammation are shown in Table 2. A significant 
(P<0.001) reduction in the weight of the cotton pellets was 
observed with MEIC (200 & 400 mg/kg) compared with the 
vehicle treated rats. However the degree of reduction was 
less than the effect caused by the standard drug aceclofenac.
3.3. Effect of MEIC on acetic acid induced writhings in mice
The extract (200 & 400 mg/kg) dose dependently reduced 
acetic acid induced writhings in mice. Maximum reduction 
was observed at the dose of 400 mg/kg. The reduction was 
statistically significant (P<0.001) when compared to control. 
The results were showed in Table 3.
3.4. Effect of MEIC on hot plate method
  The animals pretreated with MEIC (200 & 400 mg/kg) 
showed a dose dependent increase in latency of response in 
the hot plate method. The increase in the latency responses 
were significant (P<0.001). However the latency period was 
less than the effect caused by the standard drug pentazocine. 
The results were displayed in Table 4.
Table 1
Effect of methanol extract of I. cassioides on Carrageenan induced paw edema in rats.
Design of treatment
Paw volume (mL)
Percentage inhibition after 3 h
0 h 1 h 2 h 3 h
Group-I
(0.3% CMC 1 mL/kg/p.o) 0.21依0.01 0.27依0.01 0.49依0.03 0.95依0.03 -
Group-II
(Aceclofenac, 10 mg/kg/p.o) 0.21依0.01 0.24依0.01  0.28依0.01a   0.38依0.02a 60.00
Group-III
(MEIC, 200 mg/kg/p.o) 0.22依0.01 0.27依0.01  0.31依0.01a   0.38依0.01a 60.00
Group-IV
(MEIC, 400 mg/kg/p.o) 0.23依0.01 0.26依0.01  0.28依0.01a   0.32依0.02a 66.32
n=6; Data were expressed as Mean依SEM; aP<0.001 vs Control; Data were analyzed by One way ANOVA followed by Tukey Kramer Multiple 
Comparison test.
Table 2
Effect of methanol extract of I. cassioides on cotton pellet granuloma in rats.
Design of treatment Wet weight (mg) % inhibition Dry weight (mg) % inhibition
Group-I
(0.3% CMC, 1 ml/kg/p.o) 203.80依6.24 - 56.17依2.17 -
Group-II
(Aceclofenac, 10 mg/kg/p.o)    63.17依2.19a 69.00  25.50依2.08a 54.60
Group-III
(MEIC, 200 mg/kg/p.o)    76.67依2.67a 62.37    38.80依2.13a,b 30.87
Group-IV
(MEIC, 400 mg/kg/p.o)    65.00依1.88a 68.11  34.30依1.75a 38.94
n=6; Data were expressed as Mean依SEM; aP<0.001vs Control; bP<0.01 vs Aceclofenac; Data were analyzed by One way ANOVA followed by 
Tukey Kramer Multiple Comparison test.
Table 3
Effect of methanol extract of I. cassioides on chemical stimulus induced (acetic acid induced writhing) pain in mice.
Design of treatment No of writhings % reduction
Group-I (0.3 % CMC, 1 mL/kg/p.o)  105.66依3.20 -
Group-II (Aspirin, 300 mg/kg/p.o)     49.67依2.99a 53.00
Group-III (MEIC, 200 mg/kg/p.o)        66.83依2.23a,b 36.75
Group-IV (MEIC, 400 mg/kg/p.o)        50.00依2.15a,c 52.68
n=6; Data were expressed as Mean依SEM; aP<0.001vs Control; bP<0.001 vs Aspirin; cP<0.001 vs MEIC 200 mg/kg; Data were analyzed by One 
way ANOVA followed by Tukey Kramer Multiple Comparison test.
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4. Discussion
  The most widely used primary test for screening of anti-
inflammatory agents is carrageenan induced edema in the 
rat paw hind paw[12]. The development of edema in the paw 
of the rat after injection of Carrageenan is believed to be 
biphasic event. The initial phase observed during the first 
hour is attributed to the release of histamine and serotonin; 
the second phase is due to the release of prostaglandin-
like substances[16]. Based on this, it could be argued that 
the suppression of the first phase may be due to inhibition 
of the release of early mediators, such as histamine and 
serotonin, and the action in the second phase may be 
explained by an inhibition of cyclooxygenase[17]. Ueno et 
al[18] found that the injection of carrageenan into the rat paw 
induces the liberation of bradykinin, which later induces the 
biosynthesis of prostaglandins and other autocoids, which are 
responsible for the formation of the inflammatory exudates. 
Besides, in the carrageenan induced rat paw edema model, 
the production of prostanoids has been through the serum 
expression of COX-2 by a positive feedback mechanism[19]. 
There fore, it is suggested that the mechanism of action of 
MEIC may be related to prostaglandin synthesis inhibition. 
  The cotton pellet granuloma method has been widely 
employed to assess the transductive, exudative and 
proliferative components of chronic inflammation and is a 
typical feature of established chronic inflammatory reaction. 
The fluid absorbed by the pellet greatly influences the wet 
weight of the granuloma and dry weight correlates well with 
the granuloma of the granulomatous tissue formed[17,20]. 
Administration of MEIC at the doses of 200 & 400 mg/kg 
significantly reduced the granulomatous tissue formation 
when compared to control. 
  With respect to the writhing test, the research group 
of Deraedt et al[21] described the quantification of 
prostaglandins by radioimmunoassay in the peritoneal 
exudates of rats, obtained after intraperitoneal injection of 
acetic acid. They found high levels of prostaglandins PGE2毩
and PGF2毩 during the first 30 min after acetic acid 
injection. Nevertheless, it was found that the intraperitoneal 
administration of acetic acid induces the liberation not 
only of prostaglandins, but also of the sympathetic nervous 
system mediators[22, 23]. Thus the results obtained for the 
writhing test using acetic acid are similar to those obtained 
for the edematogenic test using carrageenan, since MEIC 
was effectively inhibiting the writhings in mice in dose 
dependent manner. The results were comparable with the 
group treated with aspirin. Therefore, anti-inflammatory 
substances may also be involved in the peripheral analgesic 
activity.
  It is known that non-steroidal anti-inflammatory drugs 
usually do not increase the pain threshold in normal tissues, 
whereas local anesthetics and narcotics do[24]. However, the 
hot plate test was undertaken to verify if MEIC would have 
any central analgesic effect. The results for the group treated 
with MEIC showed significant activity when compared to 
control group and nearly equal to the group treated with 
pentazocin (5 mg/kg). Hence, it is assumed that MEIC has 
significant analgesic effect on the central nervous system. 
  Preliminary phytochemical screening indicated the 
presence of flavonoids in MEIC. Selected phenolic 
compounds and flavonoids were shown to inhibit both the 
cyclooxygenase and 5-lipxygenase pathways[25-27]. This 
inhibition reduces the release of arachidonic acid. The exact 
mechanism by which flavonoids inhibit these enzymes is not 
clear. Quercetin, in particular, inhibits both cyclooxygenase 
and lipoxigenase activities, thus diminishing the formation 
of these anti-inflammatory metabolites[28,29]. Another 
anti-inflammatory feature is the ability of flavonoids to 
inhibit eicosanoid biosynthesis. Eicosanoids, such as 
prostaglandins, are involved in various immunological 
responses and are the end products of the cyclooxygenase 
and lipoxigenase pathways. Flavonoids also inhibit both 
cytosolic and membranal tyrosine kinases which play key 
roles in the signal transduction pathway that regulates cell 
proliferation[30-32]. Another anti-inflammatory property of 
flavonoids is their suggested ability to inhibit neutrophils 
degranulation. This is the direct way to diminish the release 
of arachidonic acid by neutrophils and other immune cells 
[33, 34]. From the above discussion, the methanol extract of 
Indigofera cassioides exhibited significant anti-inflammatory 
and analgesic activity.
  All these data obtained in this study point to possibly 
developing the methanol extract of Indigofera cassioides 
as a novel and potential agent in the management of 
inflammation and pain which are probably mediated via 
inhibition of various autocoids formation and release. 
Further detailed investigation is underway to determine 
the exact phytoconstituents that are responsible for these 
activities.
Table 4
Effect of methanol extract of I. cassioides on thermal stimulus induced pain in mice.
Design of treatment
Reaction time (s)
0 h 1 h 2 h 3 h
Group-I(0.3% CMC, 1 mL/kg/p.o) 2.53依0.14 2.45依0.08 2.53依0.10 2.58依0.09
Group-II(Pentazocine, 10 mg/kg/i.p) 2.40依0.13  7.41依0.35a  9.95依0.41a  8.38依0.25a
Group-III(MEIC, 200 mg/kg/p.o) 2.70依0.07    3.65依0.15b,a   5.98依0.24a,c    3.90依0.21b,c
Group-IV(MEIC, 400 mg/kg/p.o) 2.30依0.20    3.98依0.45a,c   5.80依0.21a,c  3.08依0.25c
n=6; Data were expressed as Mean依SEM; aP<0.001, bP<0.01 vs Control; cP<0.001 vs Pentazocine; Data were analyzed by One way ANOVA 
followed by Tukey Kramer Multiple Comparison test. 
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